Abbott’s below-knee stent, previously unsuccessful in heart disease patients, is now being used for severe vascular disease. The stent widens clogged blood vessels and dissolves over three years, preventing scar tissue formation. Despite Abbott’s previous dissolvable stent for coronary artery disease being pulled from the market due to low uptake, this new device shows promise for patients with vascular disease. The device’s ability to vanish and deliver a drug to prevent scar tissue formation sets it apart from traditional metal stents. Researchers are optimistic about its potential to address the challenges faced by patients with severe vascular disease.
Source link
Abbott’s new stent may help patients with peripheral artery disease
